ARCHIVES

In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB

This article is from The Cancer Letter archive.

Vol. 19 No. 30 | July 23, 1993

Download PDF Visit The Full Archive

Related Articles

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006

Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find

August 25, 2006

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004